| Literature DB >> 15790018 |
G Rossetti1, E Laffitte, P A Eigenmann, J Lübbe, D Hohl, M F Hofer.
Abstract
Atopic dermatitis (AD) is a chronic disease frequent in childhood. The treatment is based on regular moisturizing of the skin, information to the parents on the chronic course with recurrent flares, topical anti-infectious therapy for superinfections and colonization of the skin by staphylococcus aureus, and topical steroids. The immuno-modulatory macrolides (tacrolimus and pimecrolimus) represent a new alternative to topical steroids. These molecules are well tolerated, but theirs effects on the long-term are unknown. A food allergy may be responsible for a AD flare in up to a third of the cases, but the presence of an allergy should be demonstrated before the prescription of an elimination diet. AD is often the first manifestation of atopy: the physician should be aware of the future occurence of respiratory symptoms.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15790018
Source DB: PubMed Journal: Rev Med Suisse ISSN: 1660-9379